APTOSE BIOSCIENCES INC (APTO) Stock Analyst Earnings Estimates
NASDAQ:APTO - Nasdaq - CA03835T3091 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 80.52% | N/A 44.11% | N/A 37.01% | |||||||||||
| EBITDA YoY % growth | -8.654M | -12.782M -47.70% | -14.157M -10.76% | -11.742M 17.06% | -29.02M -147.15% | -26.705M 7.98% | -55.616M -108.26% | -65.297M -17.41% | -42.482M 34.94% | -52.268M -23.04% | N/A 38.92% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -8.674M | -12.857M -48.23% | -14.273M -11.01% | -11.826M 17.14% | -29.107M -146.13% | -26.857M 7.73% | -55.768M -107.65% | -65.447M -17.36% | -42.602M 34.91% | -52.356M -22.90% | N/A 13.36% | N/A 32.56% | N/A 17.99% | N/A 167.04% | N/A 537.81% | N/A 110.72% | N/A 59.03% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -0.96 89.28% | -1.10 -14.08% | N/A -1,117.63% | -0.84 93.70% | -0.52 38.09% | -0.67 -28.85% | -0.73 -8.96% | -6.75 -824.66% | -7.72 -14.37% | N/A 76.35% | N/A -22.35% | N/A 20.09% | N/A 125.51% | N/A 478.31% | N/A 105.75% | N/A 52.70% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.36 75.21% | -0.70 3.59% | -0.74 -73.16% | -0.81 -117.78% | -0.91 -154.29% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -7.344M 39.00% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -16.509M -36.13% | -11.22M -14.96% | -11.985M -63.17% | -13.005M -86.72% | -14.79M 10.41% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.37 78.98% | -1.21 | 0.84 | 69.52% |
| Q2 2024 Q2Q % growth | -0.43 81.06% | -1.20 | 0.77 | 64.27% |
| Q1 2024 Q2Q % growth | -0.73 67.56% | -0.75 | 0.02 | 3.29% |
| Q4 2023 Q2Q % growth | -1.44 12.73% | -1.63 | 0.19 | 11.49% |
| Q3 2023 Q2Q % growth | -1.76 -6.67% | -2.10 | 0.34 | 16.01% |
| Q2 2023 Q2Q % growth | -2.27 -37.58% | -2.05 | -0.22 | -10.49% |
| Q1 2023 Q2Q % growth | -2.25 -25.00% | -1.79 | -0.46 | -26.05% |
| Q4 2022 Q2Q % growth | -1.65 -511.11% | -1.68 | 0.03 | 1.96% |
| Q3 2022 Q2Q % growth | -1.65 -1,169.23% | -1.89 | 0.24 | 12.56% |
| Q2 2022 Q2Q % growth | -1.65 -1,000.00% | -1.94 | 0.29 | 14.86% |
| Q1 2022 Q2Q % growth | -1.80 -900.00% | -2.04 | 0.24 | 11.76% |
| Q4 2021 Q2Q % growth | -0.27 -68.75% | -0.18 | -0.09 | -52.72% |
| Q3 2021 Q2Q % growth | -0.13 13.33% | -0.17 | 0.04 | 21.97% |
| Q2 2021 Q2Q % growth | -0.15 28.57% | -0.19 | 0.04 | 21.22% |
| Q1 2021 Q2Q % growth | -0.18 -20.00% | -0.18 | 0.00 | -0.84% |
| Q4 2020 Q2Q % growth | -0.16 -23.08% | -0.16 | 0.00 | 1.96% |
| Q3 2020 Q2Q % growth | -0.15 -25.00% | -0.16 | 0.01 | 4.09% |
| Q2 2020 Q2Q % growth | -0.21 -61.54% | -0.15 | -0.06 | -40.37% |
| Q1 2020 Q2Q % growth | -0.15 -7.14% | -0.11 | -0.04 | -37.86% |
| Q4 2019 Q2Q % growth | -0.13 | -0.11 | -0.02 | -19.48% |
| Q3 2019 Q2Q % growth | -0.12 | -0.12 | 0.00 | 1.96% |
| Q2 2019 Q2Q % growth | -0.13 | -0.15 | 0.02 | 10.65% |
| Q1 2019 Q2Q % growth | -0.14 | -0.17 | 0.03 | 18.93% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 71.07% | 55.97% | 41.41% | 58.56% |
| Revenue | N/A | N/A | N/A | N/A |